Frandsen Jochumsen

5 ± 2.0 vs. 0.2 ± 0.4; p < 0.001).

Continuing anti-VEGF therapy after achieving functional and morphological stability every 12-14 weeks does not prevent recurrences. Patients deserve to be informed of a potential lifetime risk of recurrences, even under continued therapy.

Continuing anti-VEGF therapy after achieving functional an…[Read more]

In this study, the authors provide a better understanding of enrollment trends associated with dental plans embedded in private-sector, employer-sponsored insurance health plans for the years 2005, 2010, 2015, and2018.

Data used were from the insurance component of the Medical Expenditure Panel Survey. The authors present the number of…[Read more]

Transpapillary biliary drainage in ERCP is an established method for symptomatic treatment of patients with unresectable malignant biliary obstruction. Percutaneous transhepatic biliary drainage frequently remains the treatment of choice when the transpapillary approach proves ineffective. Recently, EUS-guided extra-anatomical anastomoses of bile…[Read more]